Avantax Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
4,723
-2,401
| -34% | -$199K | ﹤0.01% | 1730 |
|
|
2025
Q1 | $578K | Sell |
7,124
-30
| -0.4% | -$2.43K | ﹤0.01% | 1414 |
|
|
2024
Q4 | $644K | Buy |
7,154
+384
| +6% | +$34.6K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $669K | Sell |
6,770
-288
| -4% | -$28.5K | ﹤0.01% | 1236 |
|
|
2024
Q2 | $654K | Sell |
7,058
-2,561
| -27% | -$237K | ﹤0.01% | 1202 |
|
|
2024
Q1 | $913K | Buy |
9,619
+1,415
| +17% | +$134K | 0.01% | 788 |
|
|
2023
Q4 | $733K | Sell |
8,204
-5,625
| -41% | -$502K | 0.01% | 832 |
|
|
2023
Q3 | $1.01M | Sell |
13,829
-4,932
| -26% | -$360K | 0.01% | 688 |
|
|
2023
Q2 | $1.56M | Sell |
18,761
-1,561
| -8% | -$130K | 0.02% | 535 |
|
|
2023
Q1 | $1.55M | Sell |
20,322
-11,651
| -36% | -$888K | 0.02% | 517 |
|
|
2022
Q4 | $2.65M | Sell |
31,973
-5,917
| -16% | -$491K | 0.04% | 353 |
|
|
2022
Q3 | $3.01M | Buy |
37,890
+8,590
| +29% | +$681K | 0.05% | 299 |
|
|
2022
Q2 | $2.18M | Buy |
29,300
+1,935
| +7% | +$144K | 0.03% | 358 |
|
|
2022
Q1 | $2.47M | Buy |
27,365
+12,363
| +82% | +$1.11M | 0.03% | 332 |
|
|
2021
Q4 | $1.68M | Buy |
15,002
+1,282
| +9% | +$144K | 0.03% | 397 |
|
|
2021
Q3 | $1.72M | Buy |
13,720
+283
| +2% | +$35.5K | 0.03% | 369 |
|
|
2021
Q2 | $1.82M | Buy |
13,437
+96
| +0.7% | +$13K | 0.03% | 349 |
|
|
2021
Q1 | $1.81M | Sell |
13,341
-22,415
| -63% | -$3.04M | 0.04% | 306 |
|
|
2020
Q4 | $5.04M | Sell |
35,756
-10,087
| -22% | -$1.42M | 0.12% | 132 |
|
|
2020
Q3 | $5.1M | Buy |
45,843
+8,420
| +22% | +$937K | 0.08% | 209 |
|
|
2020
Q2 | $4.18M | Buy |
37,423
+22,869
| +157% | +$2.56M | 0.12% | 129 |
|
|
2020
Q1 | $1.13M | Buy |
+14,554
| New | +$1.13M | 0.03% | 281 |
|